Extramural Update May 2004 by 
The third and final year of the Fetal Basis of Adult Disease: Role of the Environment initiative will
emphasize the role of in utero and neonatal exposures to environmental chemicals in the susceptibility to
obesity and adolescent diseases, including abnormal onset of puberty. These new areas will expand the areas
of emphasis noted in past solicitations. The goal of these exploratory R21 grants is to link developmental
exposures to environmental chemicals with functional changes in
tissues or organs during development that persist and result in
increased susceptibility to disease/dysfunction later in life. 
Twenty exploratory R21 grants were funded in the first
two years of this initiative. Examples of topics funded include in
utero dioxin programming for mammary cancer, developmental
pesticide exposure and Parkinson disease, fetal dioxin exposure
and the pathology of endometriosis, fetal programming of
coronary artery disease, fetal dioxin exposure and adult heart
disease, developmental modulation of mouse uterine tumori-
genesis, and prenatal diesel fuel exposure and adult-onset asthma.
The new solicitation, released in April 2004, has a receipt
date of 12 August 2004. In addition to the new topics of obesity
and adolescent diseases/dysfunctions, the initiative also emphasizes
diseases/dysfunctions of the reproductive/endocrine system
(fertility; endometriosis; polycystic ovary syndrome; premature
menopause; prostate, ovarian, and breast cancer), the cardio-
pulmonary system (heart disease, atherosclerosis, hypertension,
chronic obstructive pulmonary disease, adult-onset asthma), the
brain/central nervous system (neurodegenerative diseases including
Parkinson disease and Alzheimer disease), and the immune and
autoimmune systems (systemic and tissue-specific autoimmune
diseases of adults, altered immune system dysfunctions). 
Applicants responding to this initiative need not have
preliminary data but must show plausibility and a scientifically solid approach to studying an
environmental agent or chemical stressor to which there is human exposure and the potential for in utero
exposure. Proposed studies must focus on in utero exposure and relate this exposure to increased
susceptibility to disease/dysfunction later in life. The in utero exposure must be shown to result in
irreversible prenatal or neonatal changes that can be mechanistically linked to the disease/dysfunction. 
The full details of this program announcement can be found on the NIEHS website at
http://www.niehs.nih.gov/dert/pa.htm.
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Neurodegenerative conditions/central nervous system
Developmental Toxicology Initiative
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